Sean Wuxiong Cao

Managing Director

Sean Wuxiong Cao is a skilled expert, who works in I-Mab Biopharma as a Chief Business Officer from 2016. Sean Wuxiong Cao gained professional experience in more than 13 positions at different companies. Sean Wuxiong Cao went to the The Wharton School and received education from 2007 to 2009. Boston, Massachusetts is the city, where this expert was lastly known to be located. Their email address and phone number are accessed through this website by request.
Name variants:
Shaun Cao, Shawn Cao, Shane Cao
Last updated Jun 17, 2024

Contact Information

Last Update
Jul 14, 2022
Email
wu**@yahoo.com
Location
Boston, MA
Company
I-Mab Biopharma

Workplace

Chief Business Officer

Work History

Chief Business Officer

Oct 2016 — Feb 2018

Director of the Board

from Aug 2017

President and Interim Chief Executive Officer

450 Lexington Ave, New York, NY 10017
from Aug 2017

Venture Partner

from Oct 2016

Managing Director

C-Bridge Capital is a China healthcare sector focused private equity fund with USD 700mm (US dollars + RMB) AUM.
from Oct 2016

President and Board Director

Responsible for the operation of Simcere of America, a wholly owned subsidiary of Simcere Pharmaceutical Group in the US.
Apr 2016 — Oct 2016

Vice President of Global Business Development

Responsible for global BD activities, including licensing, investment and M&A
Nov 1, 2015 — Oct 2016

Senior Director, Alternative Partnerships, Evaluation and Expertise

Alternative partnerships, externalization of R&D programs: out-licensing, spin-off, asset financing etc. Evaluation of external opportunities for pharma R&D.
Mar 1, 2010 — Nov 1, 2015

Director, Product Development

28 Wells Ave, Yonkers, NY 10701
A NLV portfolio company. R&D pipeline strategy, process excellence, operation efficiency. Fund raising
Sep 1, 2009 — Mar 1, 2010

Associate

420 Lexington Ave SUITE 408, New York, NY 10016
Evaluation of investment opportunities in biotech, pharma, diagnostics and medical devices
Aug 1, 2008 — Sep 1, 2009

Manager, Product Development

New Brunswick, NJ
Develop molecular diagnostic products for oncology, through FDA PMA/510K regulatory path. Six Sigma Process Excellence
May 1, 2005 — Aug 1, 2008

Senior Research Investigator

Discovery of drug targets for immuno inflammation indications. Manage external collaborations
Mar 1, 2001 — Apr 1, 2005

Post-Doc Fellow

9000 Rockville Pike, Bethesda, MD 20892
Apr 1997 — Apr 2001

Education

2007 — 2009
1991 — 1996
1984 — 1988

Occupations

Executive
Chief Executive Officer
Business Development Manager
Director
Corporate Executive
Chief Executive
Operations Manager

Skills

Biotechnology
Pharmaceutical Industry
Oncology
Drug Development
Life Sciences
Lifesciences
Commercialization
Medical Devices
Strategy
Drug Discovery
Fda
Technology Transfer
Cross Functional Team Leadership
Licensing
Venture Capital
Program Management
R&D
Clinical Trials
External Business Development
Six Sigma
Mergers and Acquisitions
Partnering
Mergers
Research and Development
R
Login